Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
BV-sete4jn2B3 A: a/b three-layered sandwichesX: Subtilisin-likeH: Subtilisin-likeT: Subtilisin-likeF: V-setECOD (v294.1)
C [auth H]Rrf2e4jn2H1 A: a/b three-layered sandwichesX: beta-GraspH: HTHT: winged helix domainF: Rrf2ECOD (v294.1)
D [auth L]RRM_1e4jn2L1 A: a/b three-layered sandwichesX: beta-GraspH: HTHT: winged helix domainF: RRM_1ECOD (v294.1)
ARRM_1e4jn2A1 A: a/b three-layered sandwichesX: beta-GraspH: HTHT: winged helix domainF: RRM_1ECOD (v294.1)

Domain Annotation: CATH CATH Database Homepage

ChainDomainClassArchitectureTopologyHomologyProvenance Source (Version)
B2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)
C [auth H]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)
D [auth L]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)
A2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
B,
C [auth H]
idarucizumab,anti-dabigatran,aDabi-Fab,antidote for dabigatran VH-CH1 Homo sapiens (human) IGHV4-59*01, IGHV4-59*02, IGHV4-59*08, IGHV4-4*08, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202614-0)
A,
D [auth L]
idarucizumab,anti-dabigatran,aDabi-Fab,antidote for dabigatran L-KAPPA Homo sapiens (human) IGKV2-30*01, IGKV2D-30*01, IGKJ4*01, IGKJ4*02, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202614-0)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
B,
C [auth H]
Heavy ChainIGHV4 -3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)-METHYL]-3-METHYL-3H-BENZOIMIDAZOLE-5-CARBONYL}-PYRIDIN-2-YL-AMINO)-PROPIONIC ACID ETHYL ESTERSAbDab (2026-04-17)
A,
D [auth L]
Light ChainIGKV2 Kappa3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)-METHYL]-3-METHYL-3H-BENZOIMIDAZOLE-5-CARBONYL}-PYRIDIN-2-YL-AMINO)-PROPIONIC ACID ETHYL ESTERSAbDab (2026-04-17)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
B,
C [auth H]
Idarucizumab DabigatranTherapeutic SAbDab (2026-04-17)
A,
D [auth L]
Idarucizumab DabigatranTherapeutic SAbDab (2026-04-17)